Efficacy and Safety Study in Pancreatic or Midgut Neuroendocrine Tumours Having Progressed Radiologically While Previously Treated With Lanreotide Autogel® 120 mg
Clinical trial NCT02651987 · COMPLETED
Trial details
- NCT number
- NCT02651987
- Sponsor
- Ipsen
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-15
- Primary completion
- 2019-10-16
- Enrollment
- 99
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.